Trial Profile

A Phase 2 Study of SNA-125 for the Treatment of Atopic Dermatitis

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 14 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SNA 125 (Primary)
Indications Atopic dermatitis
Focus Therapeutic Use
Sponsors Sienna Biopharmaceuticals

Most Recent Events

03 Dec 2018 According to a Sienna Biopharmaceuticals media release, the company plans to initiate this phase 2 study with SNA-125 in atopic dermatitis in the second half of 2019.
10 Sep 2018 New trial record
27 Aug 2018 According to a Sienna Biopharmaceuticals media release, this study is expected in the 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com